| 0 |
DRUG DELIVERY SYSTEM REMOVAL |
106 |
0.8833 |
| 1 |
PLACENTAL HYPERTROPHY |
23 |
0.5750 |
| 2 |
HEPATIC ENZYME |
74 |
0.4966 |
| 3 |
ORAL ADMINISTRATION COMPLICATION |
420 |
0.4516 |
| 4 |
INADEQUATE ANALGESIA |
3053 |
0.3590 |
| 5 |
RHESUS INCOMPATIBILITY |
33 |
0.2727 |
| 6 |
APPLICATION SITE ODOUR |
38 |
0.2621 |
| 7 |
APPLICATION SITE PERSPIRATION |
45 |
0.2601 |
| 8 |
FACET JOINT SYNDROME |
733 |
0.2249 |
| 9 |
APPLICATION SITE RASH |
3071 |
0.2231 |
| 10 |
AMAUROSIS FUGAX |
193 |
0.1792 |
| 11 |
INJECTION SITE EROSION |
60 |
0.1705 |
| 12 |
APPLICATION SITE DISCHARGE |
188 |
0.1629 |
| 13 |
APPLICATION SITE SCAR |
200 |
0.1597 |
| 14 |
APPLICATION SITE VESICLES |
1026 |
0.1580 |
| 15 |
DRUG DETOXIFICATION |
137 |
0.1532 |
| 16 |
PERIPHERAL VENOUS DISEASE |
590 |
0.1443 |
| 17 |
DRUG EFFECT INCREASED |
453 |
0.1432 |
| 18 |
APPLICATION SITE EROSION |
184 |
0.1427 |
| 19 |
APPLICATION SITE BURN |
699 |
0.1418 |
| 20 |
HYPOCHOLESTEROLAEMIA |
50 |
0.1416 |
| 21 |
APPLICATION SITE IRRITATION |
1713 |
0.1375 |
| 22 |
ONYCHOMADESIS |
567 |
0.1350 |
| 23 |
BLEPHAROSPASM |
844 |
0.1339 |
| 24 |
DRUG SCREEN NEGATIVE |
235 |
0.1334 |
| 25 |
APPLICATION SITE REACTION |
884 |
0.1256 |
| 26 |
BREAKTHROUGH PAIN |
290 |
0.1253 |
| 27 |
RHEUMATIC FEVER |
552 |
0.1237 |
| 28 |
DRUG WITHDRAWAL SYNDROME NEONATAL |
1790 |
0.1208 |
| 29 |
BREAST CANCER STAGE III |
782 |
0.1206 |
| 30 |
SWOLLEN JOINT COUNT |
27 |
0.1080 |
| 31 |
DUODENAL ULCER PERFORATION |
785 |
0.1055 |
| 32 |
APPLICATION SITE PRURITUS |
2388 |
0.1051 |
| 33 |
OVERLAP SYNDROME |
71 |
0.1014 |
| 34 |
DRUG LEVEL FLUCTUATING |
89 |
0.1002 |
| 35 |
APPLICATION SITE DISCOLOURATION |
402 |
0.0988 |
| 36 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
700 |
0.0976 |
| 37 |
PRODUCT ADHESION ISSUE |
3451 |
0.0965 |
| 38 |
ONYCHOMYCOSIS |
421 |
0.0959 |
| 39 |
SUBSTANCE USE DISORDER |
303 |
0.0950 |
| 40 |
INJECTION SITE ULCER |
89 |
0.0944 |
| 41 |
APPLICATION SITE URTICARIA |
205 |
0.0912 |
| 42 |
LEARNING DISABILITY |
468 |
0.0878 |
| 43 |
CENTRAL PAIN SYNDROME |
22 |
0.0830 |
| 44 |
DRUG WITHDRAWAL SYNDROME |
7064 |
0.0804 |
| 45 |
APPLICATION SITE PUSTULES |
29 |
0.0795 |
| 46 |
INFUSION SITE REACTION |
235 |
0.0786 |
| 47 |
DRUG DEPENDENCE |
12544 |
0.0779 |
| 48 |
MUSCLE INJURY |
646 |
0.0779 |
| 49 |
PRODUCT SOLUBILITY ABNORMAL |
383 |
0.0758 |
| 50 |
APPLICATION SITE DERMATITIS |
70 |
0.0749 |
| 51 |
FINGER DEFORMITY |
360 |
0.0742 |
| 52 |
INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION |
40 |
0.0742 |
| 53 |
HELICOBACTER INFECTION |
743 |
0.0722 |
| 54 |
TOOTH EROSION |
88 |
0.0718 |
| 55 |
FOLLICULITIS |
748 |
0.0713 |
| 56 |
CENTRAL SLEEP APNOEA SYNDROME |
23 |
0.0708 |
| 57 |
NAIL DISORDER |
610 |
0.0697 |
| 58 |
LIP DRY |
628 |
0.0691 |
| 59 |
APPLICATION SITE HYPERSENSITIVITY |
83 |
0.0683 |
| 60 |
APPLICATION SITE ERYTHEMA |
1777 |
0.0677 |
| 61 |
LIVE BIRTH |
559 |
0.0668 |
| 62 |
APPLICATION SITE ULCER |
47 |
0.0664 |
| 63 |
PEMPHIGUS |
825 |
0.0659 |
| 64 |
HYPERCHOLESTEROLAEMIA |
632 |
0.0654 |
| 65 |
BURSITIS |
788 |
0.0649 |
| 66 |
TOXICITY TO VARIOUS AGENTS |
10813 |
0.0641 |
| 67 |
C-REACTIVE PROTEIN ABNORMAL |
410 |
0.0639 |
| 68 |
VISCERAL CONGESTION |
32 |
0.0626 |
| 69 |
SUBCUTANEOUS DRUG ABSORPTION IMPAIRED |
35 |
0.0624 |
| 70 |
SUBSTANCE ABUSE |
502 |
0.0616 |
| 71 |
ACCIDENTAL POISONING |
84 |
0.0612 |
| 72 |
WOUND INFECTION |
665 |
0.0607 |
| 73 |
C-REACTIVE PROTEIN |
56 |
0.0604 |
| 74 |
LUPUS VULGARIS |
76 |
0.0603 |
| 75 |
HAND DEFORMITY |
768 |
0.0585 |
| 76 |
PRODUCT LABEL CONFUSION |
335 |
0.0574 |
| 77 |
DEEP VEIN THROMBOSIS POSTOPERATIVE |
115 |
0.0574 |
| 78 |
BACK INJURY |
618 |
0.0568 |
| 79 |
DRUG DIVERSION |
345 |
0.0558 |
| 80 |
X-RAY ABNORMAL |
99 |
0.0553 |
| 81 |
APPLICATION SITE INFECTION |
28 |
0.0550 |
| 82 |
GRIP STRENGTH DECREASED |
483 |
0.0548 |
| 83 |
EXPULSION OF MEDICATION |
28 |
0.0529 |
| 84 |
INJECTION SITE INFECTION |
168 |
0.0511 |
| 85 |
OVERDOSE |
11012 |
0.0510 |
| 86 |
INJECTION SITE NECROSIS |
103 |
0.0505 |
| 87 |
DRUG USE DISORDER |
422 |
0.0501 |
| 88 |
APPLICATION SITE BRUISE |
48 |
0.0493 |
| 89 |
DISLOCATION OF VERTEBRA |
112 |
0.0491 |
| 90 |
PLACENTAL DISORDER |
46 |
0.0486 |
| 91 |
INJECTION SITE CELLULITIS |
89 |
0.0478 |
| 92 |
APPLICATION SITE EXFOLIATION |
195 |
0.0473 |
| 93 |
PERICARDITIS |
792 |
0.0471 |
| 94 |
CONGENITAL ANOMALY |
364 |
0.0470 |
| 95 |
MYELOPATHY |
88 |
0.0463 |
| 96 |
DRUG ABUSE |
3839 |
0.0461 |
| 97 |
NEURODEGENERATIVE DISORDER |
28 |
0.0454 |
| 98 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
94 |
0.0453 |
| 99 |
EMOTIONAL DISTRESS |
5454 |
0.0450 |
| 100 |
APPLICATION SITE SCAB |
97 |
0.0449 |
| 101 |
JOINT RANGE OF MOTION DECREASED |
602 |
0.0448 |
| 102 |
SYNOVITIS |
792 |
0.0439 |
| 103 |
VICTIM OF SEXUAL ABUSE |
23 |
0.0437 |
| 104 |
URINARY TRACT DISORDER |
195 |
0.0433 |
| 105 |
APPLICATION SITE PAIN |
944 |
0.0428 |
| 106 |
DEVELOPMENTAL DELAY |
386 |
0.0427 |
| 107 |
COELIAC DISEASE |
416 |
0.0424 |
| 108 |
SWOLLEN JOINT COUNT INCREASED |
134 |
0.0420 |
| 109 |
APPLICATION SITE PAPULES |
44 |
0.0415 |
| 110 |
DRUG TOLERANCE |
210 |
0.0415 |
| 111 |
SUBSTANCE DEPENDENCE |
27 |
0.0401 |
| 112 |
INJECTION SITE ABSCESS |
99 |
0.0397 |
| 113 |
SPINA BIFIDA |
82 |
0.0393 |
| 114 |
APPLICATION SITE INFLAMMATION |
54 |
0.0390 |
| 115 |
OBESITY |
612 |
0.0384 |
| 116 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
404 |
0.0383 |
| 117 |
APPLICATION SITE DRYNESS |
128 |
0.0377 |
| 118 |
TASTE DISORDER |
755 |
0.0372 |
| 119 |
MIOSIS |
295 |
0.0367 |
| 120 |
PORPHYRIA ACUTE |
52 |
0.0362 |
| 121 |
NEONATAL RESPIRATORY DISTRESS |
34 |
0.0361 |
| 122 |
EUPHORIC MOOD |
361 |
0.0352 |
| 123 |
GLOSSODYNIA |
788 |
0.0352 |
| 124 |
QUADRIPARESIS |
58 |
0.0349 |
| 125 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
192 |
0.0347 |
| 126 |
DEFAECATION DISORDER |
23 |
0.0343 |
| 127 |
ALCOHOL ABUSE |
91 |
0.0340 |
| 128 |
BONE EROSION |
120 |
0.0339 |
| 129 |
THERAPEUTIC RESPONSE INCREASED |
31 |
0.0330 |
| 130 |
FIBROMYALGIA |
782 |
0.0321 |
| 131 |
APPLICATION SITE HAEMORRHAGE |
87 |
0.0318 |
| 132 |
DRUG SCREEN POSITIVE |
251 |
0.0317 |
| 133 |
APPLICATION SITE SWELLING |
158 |
0.0317 |
| 134 |
APPLICATION SITE WARMTH |
40 |
0.0313 |
| 135 |
DRUG EFFECT DECREASED |
1689 |
0.0313 |
| 136 |
EPILEPSY |
947 |
0.0309 |
| 137 |
SUBSTANCE USE |
48 |
0.0307 |
| 138 |
IRRITABLE BOWEL SYNDROME |
643 |
0.0300 |
| 139 |
RESPIRATORY DEPRESSION |
358 |
0.0292 |
| 140 |
EXPOSURE VIA BREAST MILK |
113 |
0.0283 |
| 141 |
HAEMORRHAGIC STROKE |
221 |
0.0283 |
| 142 |
WOUND |
791 |
0.0283 |
| 143 |
BRADYPNOEA |
76 |
0.0281 |
| 144 |
LIVER INJURY |
690 |
0.0281 |
| 145 |
RETINITIS |
46 |
0.0266 |
| 146 |
NORMAL NEWBORN |
142 |
0.0261 |
| 147 |
YAWNING |
69 |
0.0258 |
| 148 |
MULTIPLE CONGENITAL ABNORMALITIES |
37 |
0.0257 |
| 149 |
ADVERSE REACTION |
339 |
0.0255 |
| 150 |
ACCIDENTAL OVERDOSE |
913 |
0.0249 |
| 151 |
TYPE 2 DIABETES MELLITUS |
819 |
0.0243 |
| 152 |
POST-TRAUMATIC STRESS DISORDER |
163 |
0.0243 |
| 153 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
857 |
0.0241 |
| 154 |
PRODUCT CONTAMINATION |
85 |
0.0239 |
| 155 |
CONTRAINDICATED PRODUCT ADMINISTERED |
717 |
0.0237 |
| 156 |
SELF ESTEEM DECREASED |
57 |
0.0235 |
| 157 |
APPLICATION SITE DISCOMFORT |
42 |
0.0234 |
| 158 |
WITHDRAWAL SYNDROME |
974 |
0.0232 |
| 159 |
LIVER FUNCTION TEST INCREASED |
487 |
0.0227 |
| 160 |
VICTIM OF CRIME |
27 |
0.0218 |
| 161 |
JAUNDICE NEONATAL |
41 |
0.0216 |
| 162 |
RHEUMATOID FACTOR POSITIVE |
123 |
0.0213 |
| 163 |
C-REACTIVE PROTEIN INCREASED |
770 |
0.0211 |
| 164 |
PSORIATIC ARTHROPATHY |
856 |
0.0211 |
| 165 |
ASPHYXIA |
171 |
0.0209 |
| 166 |
SKIN REACTION |
293 |
0.0208 |
| 167 |
APPLICATION SITE PARAESTHESIA |
27 |
0.0207 |
| 168 |
MATERNAL EXPOSURE DURING PREGNANCY |
1846 |
0.0207 |
| 169 |
COMPARTMENT SYNDROME |
54 |
0.0207 |
| 170 |
BREECH PRESENTATION |
26 |
0.0207 |
| 171 |
IMPAIRED HEALING |
671 |
0.0204 |
| 172 |
DISABILITY |
402 |
0.0203 |
| 173 |
HEPATITIS C |
245 |
0.0203 |
| 174 |
MICROCEPHALY |
26 |
0.0203 |
| 175 |
NIGHT SWEATS |
621 |
0.0193 |
| 176 |
DENTAL CARIES |
211 |
0.0191 |
| 177 |
GAIT INABILITY |
637 |
0.0190 |
| 178 |
HOMICIDE |
35 |
0.0190 |
| 179 |
HYPERAESTHESIA |
156 |
0.0190 |
| 180 |
ALCOHOL INTERACTION |
36 |
0.0185 |
| 181 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
311 |
0.0181 |
| 182 |
IMPRISONMENT |
32 |
0.0181 |
| 183 |
ACCIDENTAL DEATH |
33 |
0.0177 |
| 184 |
GENERALISED OEDEMA |
219 |
0.0177 |
| 185 |
OCULAR DISCOMFORT |
198 |
0.0176 |
| 186 |
AUTOIMMUNE DISORDER |
171 |
0.0175 |
| 187 |
BLISTER |
946 |
0.0168 |
| 188 |
DRUG-INDUCED LIVER INJURY |
519 |
0.0165 |
| 189 |
HEPATITIS |
421 |
0.0164 |
| 190 |
FOETAL EXPOSURE DURING PREGNANCY |
1336 |
0.0164 |
| 191 |
DERMATITIS CONTACT |
186 |
0.0163 |
| 192 |
OSTEOARTHRITIS |
689 |
0.0162 |
| 193 |
LOWER RESPIRATORY TRACT INFECTION |
731 |
0.0161 |
| 194 |
ECHOCARDIOGRAM ABNORMAL |
22 |
0.0157 |
| 195 |
LOGORRHOEA |
55 |
0.0156 |
| 196 |
DEATH |
13431 |
0.0156 |
| 197 |
BLOOD CHOLESTEROL INCREASED |
721 |
0.0155 |
| 198 |
SEDATION |
403 |
0.0154 |
| 199 |
CLUSTER HEADACHE |
21 |
0.0154 |
| 200 |
INFLAMMATION |
793 |
0.0153 |
| 201 |
GUN SHOT WOUND |
29 |
0.0153 |
| 202 |
BREAST CANCER STAGE II |
127 |
0.0152 |
| 203 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
682 |
0.0152 |
| 204 |
LABELLED DRUG-DRUG INTERACTION ISSUE |
22 |
0.0152 |
| 205 |
ARTHROPATHY |
845 |
0.0152 |
| 206 |
PERSECUTORY DELUSION |
37 |
0.0148 |
| 207 |
FOETAL DISTRESS SYNDROME |
31 |
0.0146 |
| 208 |
JUDGEMENT IMPAIRED |
21 |
0.0144 |
| 209 |
ULCER HAEMORRHAGE |
97 |
0.0143 |
| 210 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
37 |
0.0141 |
| 211 |
ALTERED STATE OF CONSCIOUSNESS |
301 |
0.0139 |
| 212 |
EXPOSURE DURING PREGNANCY |
858 |
0.0138 |
| 213 |
THERAPEUTIC RESPONSE DELAYED |
38 |
0.0136 |
| 214 |
PAIN |
8340 |
0.0136 |
| 215 |
INJECTION SITE OEDEMA |
23 |
0.0134 |
| 216 |
LUNG DISORDER |
653 |
0.0133 |
| 217 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
50 |
0.0133 |
| 218 |
IMPAIRED DRIVING ABILITY |
151 |
0.0133 |
| 219 |
DRUG INTOLERANCE |
1273 |
0.0132 |
| 220 |
FOCAL SEGMENTAL GLOMERULOSCLEROSIS |
21 |
0.0131 |
| 221 |
THERMAL BURN |
93 |
0.0131 |
| 222 |
EXOSTOSIS |
119 |
0.0130 |
| 223 |
PSYCHOMOTOR SKILLS IMPAIRED |
34 |
0.0130 |
| 224 |
SUBSTANCE-INDUCED PSYCHOTIC DISORDER |
29 |
0.0130 |
| 225 |
SKIN IRRITATION |
584 |
0.0127 |
| 226 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
461 |
0.0127 |
| 227 |
GENERAL PHYSICAL CONDITION ABNORMAL |
86 |
0.0127 |
| 228 |
INJECTION SITE EXTRAVASATION |
156 |
0.0126 |
| 229 |
MENTAL DISORDER |
550 |
0.0126 |
| 230 |
HEAD DISCOMFORT |
223 |
0.0126 |
| 231 |
BRAIN OEDEMA |
159 |
0.0126 |
| 232 |
WHEEZING |
744 |
0.0125 |
| 233 |
PRODUCT COLOUR ISSUE |
64 |
0.0125 |
| 234 |
STOMATITIS |
748 |
0.0123 |
| 235 |
SMALL FOR DATES BABY |
61 |
0.0123 |
| 236 |
INFUSION RELATED REACTION |
810 |
0.0122 |
| 237 |
HYPOPNOEA |
42 |
0.0121 |
| 238 |
GASTROOESOPHAGEAL REFLUX DISEASE |
973 |
0.0121 |
| 239 |
INTENTIONAL PRODUCT USE ISSUE |
1056 |
0.0120 |
| 240 |
INJURY |
842 |
0.0120 |
| 241 |
EXTRA DOSE ADMINISTERED |
483 |
0.0119 |
| 242 |
EXPOSURE DURING BREAST FEEDING |
39 |
0.0118 |
| 243 |
CLUMSINESS |
32 |
0.0117 |
| 244 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
72 |
0.0116 |
| 245 |
PRODUCT PHYSICAL ISSUE |
234 |
0.0116 |
| 246 |
NECK PAIN |
646 |
0.0115 |
| 247 |
HAEMATEMESIS |
291 |
0.0115 |
| 248 |
DRY MOUTH |
927 |
0.0114 |
| 249 |
CLEFT PALATE |
22 |
0.0114 |
| 250 |
MUSCULOSKELETAL PAIN |
595 |
0.0113 |
| 251 |
PUSTULAR PSORIASIS |
39 |
0.0113 |
| 252 |
INJECTION SITE DISCHARGE |
61 |
0.0113 |
| 253 |
MEDICATION RESIDUE PRESENT |
54 |
0.0113 |
| 254 |
HEPATIC ENZYME INCREASED |
759 |
0.0111 |
| 255 |
PRODUCT PACKAGING DIFFICULT TO OPEN |
29 |
0.0111 |
| 256 |
BEHAVIOUR DISORDER |
60 |
0.0111 |
| 257 |
PHOTOPHOBIA |
208 |
0.0110 |
| 258 |
DRUG TOLERANCE DECREASED |
31 |
0.0110 |
| 259 |
BLOOD PRESSURE DIASTOLIC ABNORMAL |
28 |
0.0110 |
| 260 |
RASH VESICULAR |
53 |
0.0110 |
| 261 |
INTENTIONAL PRODUCT MISUSE |
954 |
0.0109 |
| 262 |
POISONING |
136 |
0.0108 |
| 263 |
SLEEP DISORDER |
763 |
0.0108 |
| 264 |
COMA |
510 |
0.0107 |
| 265 |
TOOTH LOSS |
221 |
0.0106 |
| 266 |
HYPERCAPNIA |
32 |
0.0106 |
| 267 |
ALCOHOL POISONING |
28 |
0.0104 |
| 268 |
FEELING OF BODY TEMPERATURE CHANGE |
61 |
0.0104 |
| 269 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
115 |
0.0104 |
| 270 |
TONGUE DISCOMFORT |
44 |
0.0104 |
| 271 |
PRODUCT DISPENSING ISSUE |
44 |
0.0103 |
| 272 |
CONFUSIONAL STATE |
1651 |
0.0102 |
| 273 |
SEDATION COMPLICATION |
26 |
0.0102 |
| 274 |
RESPIRATORY RATE DECREASED |
32 |
0.0102 |
| 275 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
66 |
0.0102 |
| 276 |
PRESCRIBED OVERDOSE |
195 |
0.0101 |
| 277 |
INJECTION SITE INFLAMMATION |
50 |
0.0100 |
| 278 |
DEAFNESS NEUROSENSORY |
33 |
0.0100 |
| 279 |
ENDOCARDITIS |
51 |
0.0099 |
| 280 |
HYPERHIDROSIS |
1272 |
0.0099 |
| 281 |
PRESYNCOPE |
239 |
0.0098 |
| 282 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1134 |
0.0098 |
| 283 |
MIGRAINE |
934 |
0.0098 |
| 284 |
POISONING DELIBERATE |
92 |
0.0097 |
| 285 |
TOOTH INJURY |
42 |
0.0097 |
| 286 |
MOBILITY DECREASED |
688 |
0.0096 |
| 287 |
DERMATITIS ALLERGIC |
119 |
0.0095 |
| 288 |
DIPLOPIA |
241 |
0.0093 |
| 289 |
LUPUS-LIKE SYNDROME |
84 |
0.0093 |
| 290 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
39 |
0.0093 |
| 291 |
SWELLING |
846 |
0.0090 |
| 292 |
BRAIN INJURY |
90 |
0.0090 |
| 293 |
LOW BIRTH WEIGHT BABY |
71 |
0.0089 |
| 294 |
SCIATICA |
142 |
0.0089 |
| 295 |
TOOTH FRACTURE |
98 |
0.0089 |
| 296 |
URINARY HESITATION |
21 |
0.0088 |
| 297 |
ROAD TRAFFIC ACCIDENT |
365 |
0.0087 |
| 298 |
DELIRIUM |
302 |
0.0087 |
| 299 |
CARDIO-RESPIRATORY ARREST |
362 |
0.0086 |
| 300 |
WALKING AID USER |
57 |
0.0086 |
| 301 |
SOMNOLENCE |
1727 |
0.0086 |
| 302 |
INJECTION SITE INDURATION |
110 |
0.0085 |
| 303 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
601 |
0.0084 |
| 304 |
ANXIETY DISORDER |
28 |
0.0084 |
| 305 |
INCOHERENT |
54 |
0.0083 |
| 306 |
MENTAL IMPAIRMENT |
202 |
0.0083 |
| 307 |
SEROTONIN SYNDROME |
160 |
0.0083 |
| 308 |
STRESS CARDIOMYOPATHY |
48 |
0.0082 |
| 309 |
ILL-DEFINED DISORDER |
501 |
0.0082 |
| 310 |
SLOW SPEECH |
20 |
0.0082 |
| 311 |
EYE INJURY |
25 |
0.0082 |
| 312 |
ELECTRIC SHOCK SENSATION |
23 |
0.0082 |
| 313 |
PRODUCT SIZE ISSUE |
44 |
0.0082 |
| 314 |
LOWER LIMB FRACTURE |
157 |
0.0082 |
| 315 |
DEPRESSION |
1851 |
0.0081 |
| 316 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
149 |
0.0081 |
| 317 |
FOETAL GROWTH RESTRICTION |
49 |
0.0081 |
| 318 |
QUALITY OF LIFE DECREASED |
108 |
0.0080 |
| 319 |
POTENTIATING DRUG INTERACTION |
27 |
0.0080 |
| 320 |
PARANOIA |
138 |
0.0080 |
| 321 |
SPINAL STENOSIS |
33 |
0.0080 |
| 322 |
ORAL DISCOMFORT |
111 |
0.0080 |
| 323 |
THERAPEUTIC RESPONSE SHORTENED |
264 |
0.0080 |
| 324 |
PREMATURE DELIVERY |
126 |
0.0079 |
| 325 |
DYSPHORIA |
40 |
0.0079 |
| 326 |
RHEUMATOID ARTHRITIS |
897 |
0.0079 |
| 327 |
INJECTION SITE REACTION |
543 |
0.0079 |
| 328 |
NECK INJURY |
23 |
0.0078 |
| 329 |
HYPOAESTHESIA |
1160 |
0.0077 |
| 330 |
INJECTION SITE SCAR |
22 |
0.0077 |
| 331 |
SPINAL FUSION SURGERY |
31 |
0.0076 |
| 332 |
AFFECTIVE DISORDER |
60 |
0.0076 |
| 333 |
SOMNAMBULISM |
50 |
0.0076 |
| 334 |
MONOPLEGIA |
33 |
0.0076 |
| 335 |
COMMUNICATION DISORDER |
29 |
0.0076 |
| 336 |
UNEVALUABLE EVENT |
572 |
0.0076 |
| 337 |
MAJOR DEPRESSION |
55 |
0.0075 |
| 338 |
LOSS OF EMPLOYMENT |
22 |
0.0073 |
| 339 |
CRANIOCEREBRAL INJURY |
22 |
0.0073 |
| 340 |
COMA SCALE ABNORMAL |
21 |
0.0072 |
| 341 |
MEMORY IMPAIRMENT |
993 |
0.0072 |
| 342 |
ASCITES |
212 |
0.0072 |
| 343 |
IMPAIRED WORK ABILITY |
154 |
0.0072 |
| 344 |
RESTLESS LEGS SYNDROME |
128 |
0.0070 |
| 345 |
TREATMENT FAILURE |
583 |
0.0070 |
| 346 |
FEELING DRUNK |
52 |
0.0070 |
| 347 |
HEPATIC FIBROSIS |
24 |
0.0070 |
| 348 |
BRADYKINESIA |
41 |
0.0069 |
| 349 |
INJECTION SITE VESICLES |
42 |
0.0069 |
| 350 |
TACHYPHRENIA |
24 |
0.0069 |
| 351 |
TOXIC ENCEPHALOPATHY |
35 |
0.0069 |
| 352 |
BLINDNESS |
281 |
0.0069 |
| 353 |
HALLUCINATION |
519 |
0.0069 |
| 354 |
IMPAIRED QUALITY OF LIFE |
99 |
0.0069 |
| 355 |
SPONDYLITIS |
25 |
0.0069 |
| 356 |
ASPIRATION |
75 |
0.0068 |
| 357 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
487 |
0.0068 |
| 358 |
TOOTHACHE |
123 |
0.0068 |
| 359 |
EAR PAIN |
132 |
0.0068 |
| 360 |
ALCOHOLISM |
29 |
0.0068 |
| 361 |
DYSARTHRIA |
255 |
0.0068 |
| 362 |
HEPATIC CIRRHOSIS |
127 |
0.0068 |
| 363 |
THERAPEUTIC RESPONSE DECREASED |
409 |
0.0067 |
| 364 |
PARAESTHESIA |
1057 |
0.0067 |
| 365 |
HAEMATURIA |
230 |
0.0067 |
| 366 |
GASTROINTESTINAL DISORDER |
601 |
0.0067 |
| 367 |
TINNITUS |
308 |
0.0067 |
| 368 |
UNRESPONSIVE TO STIMULI |
173 |
0.0067 |
| 369 |
JOINT SWELLING |
809 |
0.0067 |
| 370 |
INTENTIONAL UNDERDOSE |
48 |
0.0066 |
| 371 |
PRODUCT QUALITY ISSUE |
890 |
0.0065 |
| 372 |
MUSCULAR WEAKNESS |
742 |
0.0065 |
| 373 |
AMNESIA |
422 |
0.0065 |
| 374 |
ABDOMINAL PAIN UPPER |
1330 |
0.0065 |
| 375 |
MUSCULOSKELETAL STIFFNESS |
564 |
0.0064 |
| 376 |
DYSPEPSIA |
633 |
0.0064 |
| 377 |
INJECTION SITE HYPERSENSITIVITY |
20 |
0.0064 |
| 378 |
ANXIETY |
1788 |
0.0063 |
| 379 |
TONGUE ULCERATION |
21 |
0.0062 |
| 380 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
42 |
0.0062 |
| 381 |
AGGRESSION |
308 |
0.0061 |
| 382 |
ABDOMINAL DISCOMFORT |
1032 |
0.0061 |
| 383 |
SKIN ABRASION |
29 |
0.0061 |
| 384 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
294 |
0.0061 |
| 385 |
PULMONARY FIBROSIS |
117 |
0.0061 |
| 386 |
PRE-EXISTING CONDITION IMPROVED |
38 |
0.0061 |
| 387 |
DISORIENTATION |
241 |
0.0061 |
| 388 |
MYDRIASIS |
78 |
0.0061 |
| 389 |
TACHYCARDIA |
540 |
0.0061 |
| 390 |
DRUG INTERACTION |
964 |
0.0061 |
| 391 |
MOUTH SWELLING |
35 |
0.0061 |
| 392 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1226 |
0.0060 |
| 393 |
PERSONALITY CHANGE |
56 |
0.0060 |
| 394 |
CONJUNCTIVAL HAEMORRHAGE |
23 |
0.0060 |
| 395 |
RASH |
2616 |
0.0060 |
| 396 |
BIPOLAR DISORDER |
65 |
0.0060 |
| 397 |
PRURITUS GENERALISED |
129 |
0.0060 |
| 398 |
PANIC DISORDER |
23 |
0.0059 |
| 399 |
RESTLESSNESS |
215 |
0.0059 |
| 400 |
BEDRIDDEN |
77 |
0.0059 |
| 401 |
DISCOMFORT |
357 |
0.0058 |
| 402 |
RESPIRATORY ACIDOSIS |
23 |
0.0058 |
| 403 |
PREMATURE BABY |
176 |
0.0058 |
| 404 |
PULMONARY CONGESTION |
77 |
0.0058 |
| 405 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
99 |
0.0058 |
| 406 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
230 |
0.0058 |
| 407 |
NAUSEA |
4596 |
0.0058 |
| 408 |
FOETAL DEATH |
30 |
0.0058 |
| 409 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
125 |
0.0058 |
| 410 |
SUICIDAL BEHAVIOUR |
24 |
0.0058 |
| 411 |
PRESCRIBED UNDERDOSE |
115 |
0.0058 |
| 412 |
PRODUCT FORMULATION ISSUE |
38 |
0.0058 |
| 413 |
RESPIRATORY ARREST |
157 |
0.0057 |
| 414 |
RHABDOMYOLYSIS |
236 |
0.0057 |
| 415 |
PERIPHERAL SWELLING |
871 |
0.0056 |
| 416 |
NEONATAL RESPIRATORY DISTRESS SYNDROME |
20 |
0.0056 |
| 417 |
PNEUMONIA ASPIRATION |
141 |
0.0056 |
| 418 |
PRODUCT ADMINISTRATION ERROR |
113 |
0.0056 |
| 419 |
DIZZINESS |
2787 |
0.0056 |
| 420 |
OVERWEIGHT |
30 |
0.0056 |
| 421 |
COLD SWEAT |
98 |
0.0056 |
| 422 |
SUICIDAL IDEATION |
508 |
0.0055 |
| 423 |
PRODUCT TASTE ABNORMAL |
75 |
0.0055 |
| 424 |
INSOMNIA |
1472 |
0.0055 |
| 425 |
PRODUCT ADMINISTRATION INTERRUPTED |
43 |
0.0055 |
| 426 |
PULMONARY OEDEMA |
244 |
0.0054 |
| 427 |
HOMICIDAL IDEATION |
22 |
0.0054 |
| 428 |
INJECTION SITE IRRITATION |
69 |
0.0054 |
| 429 |
BODY TEMPERATURE DECREASED |
53 |
0.0054 |
| 430 |
BRADYPHRENIA |
35 |
0.0054 |
| 431 |
BONE DENSITY ABNORMAL |
20 |
0.0053 |
| 432 |
AGITATION |
392 |
0.0053 |
| 433 |
URTICARIA |
891 |
0.0053 |
| 434 |
ABDOMINAL DISTENSION |
553 |
0.0053 |
| 435 |
FAECALOMA |
29 |
0.0053 |
| 436 |
VOMITING |
2481 |
0.0053 |
| 437 |
URINARY RETENTION |
174 |
0.0052 |
| 438 |
HEART RATE ABNORMAL |
29 |
0.0052 |
| 439 |
DRUG EFFECT LESS THAN EXPECTED |
77 |
0.0052 |
| 440 |
SOCIAL AVOIDANT BEHAVIOUR |
30 |
0.0052 |
| 441 |
FEELING OF DESPAIR |
24 |
0.0051 |
| 442 |
MUSCLE SPASMS |
937 |
0.0051 |
| 443 |
VENOUS THROMBOSIS |
20 |
0.0051 |
| 444 |
DELUSION |
79 |
0.0051 |
| 445 |
HYPERTONIA |
29 |
0.0051 |
| 446 |
CACHEXIA |
26 |
0.0050 |
| 447 |
PRE-ECLAMPSIA |
24 |
0.0050 |
| 448 |
DISTURBANCE IN ATTENTION |
272 |
0.0050 |
| 449 |
FORMICATION |
35 |
0.0050 |
| 450 |
HALLUCINATIONS, MIXED |
21 |
0.0050 |
| 451 |
LETHARGY |
286 |
0.0050 |
| 452 |
HIP ARTHROPLASTY |
76 |
0.0050 |
| 453 |
MYOCLONUS |
59 |
0.0049 |
| 454 |
PRODUCT PACKAGING ISSUE |
47 |
0.0049 |
| 455 |
DEPENDENCE |
271 |
0.0049 |
| 456 |
MUSCLE RIGIDITY |
59 |
0.0049 |
| 457 |
COGNITIVE DISORDER |
230 |
0.0049 |
| 458 |
SUSPECTED SUICIDE |
23 |
0.0049 |
| 459 |
DRUG INEFFECTIVE |
6458 |
0.0049 |
| 460 |
APNOEA |
38 |
0.0049 |
| 461 |
SUSPECTED OFF LABEL USE |
22 |
0.0049 |
| 462 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
25 |
0.0049 |
| 463 |
PRODUCT PRESCRIBING ISSUE |
106 |
0.0049 |
| 464 |
GASTROINTESTINAL MOTILITY DISORDER |
26 |
0.0049 |
| 465 |
DRUG EFFECT DELAYED |
22 |
0.0048 |
| 466 |
SUICIDE ATTEMPT |
294 |
0.0048 |
| 467 |
BLOOD PRESSURE SYSTOLIC DECREASED |
22 |
0.0048 |
| 468 |
HYPERTENSION |
1022 |
0.0048 |
| 469 |
ABNORMAL BEHAVIOUR |
189 |
0.0048 |
| 470 |
RESPIRATORY DISORDER |
142 |
0.0047 |
| 471 |
PRODUCT PRESCRIBING ERROR |
113 |
0.0047 |
| 472 |
TORSADE DE POINTES |
37 |
0.0047 |
| 473 |
SCREAMING |
30 |
0.0047 |
| 474 |
HALLUCINATION, VISUAL |
98 |
0.0046 |
| 475 |
BRUXISM |
25 |
0.0046 |
| 476 |
SPINAL OPERATION |
57 |
0.0046 |
| 477 |
TOOTH DISORDER |
102 |
0.0046 |
| 478 |
ABNORMAL LOSS OF WEIGHT |
31 |
0.0045 |
| 479 |
JOINT STIFFNESS |
118 |
0.0045 |
| 480 |
HYPERVENTILATION |
26 |
0.0045 |
| 481 |
PSYCHOTIC DISORDER |
132 |
0.0045 |
| 482 |
CONSTIPATION |
973 |
0.0045 |
| 483 |
ALOPECIA |
876 |
0.0045 |
| 484 |
HYPERTHERMIA |
34 |
0.0044 |
| 485 |
SCHIZOPHRENIA |
54 |
0.0044 |
| 486 |
FEELING ABNORMAL |
1049 |
0.0044 |
| 487 |
OEDEMA |
237 |
0.0044 |
| 488 |
FEELING JITTERY |
83 |
0.0044 |
| 489 |
ACCIDENT |
52 |
0.0044 |
| 490 |
JOINT DISLOCATION |
46 |
0.0043 |
| 491 |
SLEEP APNOEA SYNDROME |
83 |
0.0043 |
| 492 |
MYOSITIS |
39 |
0.0043 |
| 493 |
HALLUCINATION, AUDITORY |
69 |
0.0043 |
| 494 |
NERVE INJURY |
48 |
0.0043 |
| 495 |
THINKING ABNORMAL |
80 |
0.0043 |
| 496 |
NASOPHARYNGITIS |
786 |
0.0043 |
| 497 |
SKIN NECROSIS |
22 |
0.0042 |
| 498 |
ANGER |
143 |
0.0042 |
| 499 |
CARDIOMEGALY |
52 |
0.0042 |
| 500 |
PRODUCT USE ISSUE |
785 |
0.0042 |
| 501 |
MATERNAL DRUGS AFFECTING FOETUS |
32 |
0.0042 |
| 502 |
SYNCOPE |
410 |
0.0041 |
| 503 |
DECREASED INTEREST |
24 |
0.0041 |
| 504 |
OEDEMA PERIPHERAL |
496 |
0.0041 |
| 505 |
BLOOD PRESSURE DIASTOLIC DECREASED |
30 |
0.0041 |
| 506 |
DEVICE LEAKAGE |
176 |
0.0041 |
| 507 |
HYPERSOMNIA |
116 |
0.0040 |
| 508 |
CONDITION AGGRAVATED |
1230 |
0.0040 |
| 509 |
EYE PAIN |
228 |
0.0040 |
| 510 |
ASTHENIA |
1519 |
0.0040 |
| 511 |
CHILLS |
469 |
0.0040 |
| 512 |
APATHY |
58 |
0.0040 |
| 513 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
35 |
0.0040 |
| 514 |
FALL |
1304 |
0.0039 |
| 515 |
PRODUCT SUBSTITUTION ISSUE |
225 |
0.0039 |
| 516 |
INTERVERTEBRAL DISC DEGENERATION |
36 |
0.0039 |
| 517 |
CYANOSIS |
61 |
0.0039 |
| 518 |
RESPIRATORY DISTRESS |
107 |
0.0039 |
| 519 |
HYPOTHERMIA |
39 |
0.0038 |
| 520 |
HEADACHE |
2414 |
0.0038 |
| 521 |
FAECES SOFT |
28 |
0.0038 |
| 522 |
WEIGHT INCREASED |
862 |
0.0038 |
| 523 |
SEXUAL DYSFUNCTION |
45 |
0.0038 |
| 524 |
RASH GENERALISED |
99 |
0.0038 |
| 525 |
CARDIAC DISORDER |
356 |
0.0038 |
| 526 |
BLOOD TESTOSTERONE DECREASED |
26 |
0.0038 |
| 527 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
685 |
0.0038 |
| 528 |
SPINAL OSTEOARTHRITIS |
33 |
0.0038 |
| 529 |
SPINAL PAIN |
44 |
0.0038 |
| 530 |
LOSS OF CONSCIOUSNESS |
481 |
0.0038 |
| 531 |
PANIC REACTION |
27 |
0.0037 |
| 532 |
GENERAL SYMPTOM |
28 |
0.0037 |
| 533 |
DECREASED APPETITE |
865 |
0.0037 |
| 534 |
PRODUCT ODOUR ABNORMAL |
39 |
0.0037 |
| 535 |
PRODUCT USE IN UNAPPROVED INDICATION |
921 |
0.0037 |
| 536 |
NEUROLEPTIC MALIGNANT SYNDROME |
44 |
0.0037 |
| 537 |
GINGIVITIS |
20 |
0.0037 |
| 538 |
HYPERSENSITIVITY |
684 |
0.0037 |
| 539 |
DRUG LEVEL INCREASED |
60 |
0.0036 |
| 540 |
SUDDEN DEATH |
38 |
0.0036 |
| 541 |
SPUTUM DISCOLOURED |
34 |
0.0036 |
| 542 |
ENERGY INCREASED |
21 |
0.0036 |
| 543 |
LIVER DISORDER |
157 |
0.0035 |
| 544 |
DRUG LEVEL DECREASED |
36 |
0.0035 |
| 545 |
IMPAIRED GASTRIC EMPTYING |
48 |
0.0035 |
| 546 |
ARTHRALGIA |
1459 |
0.0035 |
| 547 |
MALAISE |
1536 |
0.0035 |
| 548 |
NEURALGIA |
85 |
0.0035 |
| 549 |
SENSORY DISTURBANCE |
56 |
0.0035 |
| 550 |
ARTERIOSCLEROSIS CORONARY ARTERY |
23 |
0.0035 |
| 551 |
DEMENTIA |
97 |
0.0035 |
| 552 |
UROSEPSIS |
32 |
0.0035 |
| 553 |
LOSS OF LIBIDO |
31 |
0.0034 |
| 554 |
SCAR |
59 |
0.0034 |
| 555 |
BACK DISORDER |
56 |
0.0034 |
| 556 |
PANIC ATTACK |
125 |
0.0034 |
| 557 |
PRODUCT USE COMPLAINT |
54 |
0.0034 |
| 558 |
PHARYNGITIS STREPTOCOCCAL |
37 |
0.0034 |
| 559 |
DRUG ABUSER |
21 |
0.0034 |
| 560 |
UNDERDOSE |
248 |
0.0034 |
| 561 |
MALNUTRITION |
38 |
0.0034 |
| 562 |
NIGHTMARE |
117 |
0.0034 |
| 563 |
CONTUSION |
324 |
0.0034 |
| 564 |
FACIAL PAIN |
30 |
0.0034 |
| 565 |
INJECTION SITE WARMTH |
69 |
0.0034 |
| 566 |
ENCEPHALOPATHY |
82 |
0.0033 |
| 567 |
INJECTION SITE PAIN |
1024 |
0.0033 |
| 568 |
MOOD SWINGS |
106 |
0.0033 |
| 569 |
ERECTILE DYSFUNCTION |
85 |
0.0033 |
| 570 |
SEPSIS |
368 |
0.0033 |
| 571 |
PRODUCT COMMUNICATION ISSUE |
29 |
0.0033 |
| 572 |
KNEE ARTHROPLASTY |
69 |
0.0033 |
| 573 |
IRRITABILITY |
197 |
0.0033 |
| 574 |
INTENTIONAL SELF-INJURY |
66 |
0.0033 |
| 575 |
GINGIVAL PAIN |
26 |
0.0033 |
| 576 |
SEIZURE |
377 |
0.0033 |
| 577 |
MUSCLE TWITCHING |
75 |
0.0033 |
| 578 |
SOPOR |
43 |
0.0032 |
| 579 |
DYSURIA |
119 |
0.0032 |
| 580 |
ABDOMINAL PAIN |
748 |
0.0032 |
| 581 |
PRODUCT DISPENSING ERROR |
70 |
0.0032 |
| 582 |
DYSPNOEA |
1808 |
0.0032 |
| 583 |
LIP SWELLING |
106 |
0.0032 |
| 584 |
ADVERSE DRUG REACTION |
285 |
0.0032 |
| 585 |
NO ADVERSE EVENT |
573 |
0.0032 |
| 586 |
PRURITUS |
1213 |
0.0032 |
| 587 |
COORDINATION ABNORMAL |
44 |
0.0032 |
| 588 |
LOCAL SWELLING |
55 |
0.0031 |
| 589 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
53 |
0.0031 |
| 590 |
PREGNANCY |
63 |
0.0031 |
| 591 |
COMPLETED SUICIDE |
262 |
0.0031 |
| 592 |
SENSITIVE SKIN |
23 |
0.0031 |
| 593 |
CEREBRAL DISORDER |
23 |
0.0031 |
| 594 |
ORTHOSTATIC HYPOTENSION |
54 |
0.0031 |
| 595 |
PNEUMONIA |
1002 |
0.0031 |
| 596 |
DIZZINESS POSTURAL |
30 |
0.0031 |
| 597 |
ADVERSE EVENT |
284 |
0.0031 |
| 598 |
INJECTION SITE ERYTHEMA |
382 |
0.0031 |
| 599 |
DROOLING |
21 |
0.0030 |
| 600 |
PAIN IN EXTREMITY |
886 |
0.0030 |
| 601 |
MEDICATION ERROR |
167 |
0.0030 |
| 602 |
FEELING HOT |
184 |
0.0030 |
| 603 |
BRAIN FOG |
47 |
0.0030 |
| 604 |
ILLNESS |
307 |
0.0030 |
| 605 |
TREMOR |
494 |
0.0030 |
| 606 |
ELECTROCARDIOGRAM QT PROLONGED |
107 |
0.0030 |
| 607 |
URINARY INCONTINENCE |
88 |
0.0030 |
| 608 |
THERAPY NON-RESPONDER |
133 |
0.0030 |
| 609 |
OSTEOPOROSIS |
121 |
0.0029 |
| 610 |
PALPITATIONS |
344 |
0.0029 |
| 611 |
INTENTIONAL OVERDOSE |
188 |
0.0029 |
| 612 |
MUSCLE SPASTICITY |
36 |
0.0029 |
| 613 |
CAESAREAN SECTION |
34 |
0.0029 |
| 614 |
INJECTION SITE NODULE |
32 |
0.0029 |
| 615 |
RESPIRATION ABNORMAL |
20 |
0.0029 |
| 616 |
FOOT DEFORMITY |
32 |
0.0029 |
| 617 |
POOR QUALITY SLEEP |
62 |
0.0029 |
| 618 |
GASTRIC ULCER |
54 |
0.0028 |
| 619 |
INJECTION SITE MASS |
105 |
0.0028 |
| 620 |
BLOOD PRESSURE INCREASED |
430 |
0.0028 |
| 621 |
HYPOXIA |
99 |
0.0028 |
| 622 |
IMMUNE SYSTEM DISORDER |
37 |
0.0028 |
| 623 |
HYDRONEPHROSIS |
21 |
0.0028 |
| 624 |
HYPOTONIA |
28 |
0.0028 |
| 625 |
SALIVARY HYPERSECRETION |
28 |
0.0028 |
| 626 |
RIB FRACTURE |
57 |
0.0028 |
| 627 |
INJECTION SITE DISCOMFORT |
29 |
0.0028 |
| 628 |
TOOTH ABSCESS |
28 |
0.0027 |
| 629 |
TOOTH EXTRACTION |
34 |
0.0027 |
| 630 |
FREQUENT BOWEL MOVEMENTS |
73 |
0.0027 |
| 631 |
SWOLLEN TONGUE |
84 |
0.0027 |
| 632 |
TENDERNESS |
28 |
0.0027 |
| 633 |
MUSCLE ATROPHY |
34 |
0.0027 |
| 634 |
INTENTIONAL DRUG MISUSE |
56 |
0.0027 |
| 635 |
CHEST PAIN |
495 |
0.0027 |
| 636 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
47 |
0.0027 |
| 637 |
BURNING SENSATION |
186 |
0.0026 |
| 638 |
BLOOD ALBUMIN DECREASED |
21 |
0.0026 |
| 639 |
HOSPITALISATION |
406 |
0.0026 |
| 640 |
INJECTION SITE DISCOLOURATION |
33 |
0.0026 |
| 641 |
FATIGUE |
2054 |
0.0026 |
| 642 |
FOOT FRACTURE |
50 |
0.0026 |
| 643 |
MENTAL STATUS CHANGES |
73 |
0.0026 |
| 644 |
FEELING COLD |
73 |
0.0026 |
| 645 |
MYALGIA |
444 |
0.0026 |
| 646 |
OFF LABEL USE |
2273 |
0.0026 |
| 647 |
POLYNEUROPATHY |
31 |
0.0026 |
| 648 |
CRYING |
94 |
0.0026 |
| 649 |
WEIGHT FLUCTUATION |
27 |
0.0026 |
| 650 |
OXYGEN SATURATION DECREASED |
145 |
0.0026 |
| 651 |
CARDIAC ARREST |
213 |
0.0026 |
| 652 |
DEPRESSED MOOD |
135 |
0.0026 |
| 653 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
133 |
0.0025 |
| 654 |
SCAB |
29 |
0.0025 |
| 655 |
DEVICE ADHESION ISSUE |
39 |
0.0025 |
| 656 |
GENERALISED TONIC-CLONIC SEIZURE |
42 |
0.0025 |
| 657 |
CHROMATURIA |
57 |
0.0025 |
| 658 |
INJECTION SITE PRURITUS |
168 |
0.0025 |
| 659 |
TACHYPNOEA |
34 |
0.0025 |
| 660 |
CARPAL TUNNEL SYNDROME |
35 |
0.0025 |
| 661 |
BLOOD DISORDER |
20 |
0.0025 |
| 662 |
AFFECT LABILITY |
24 |
0.0025 |
| 663 |
MOOD ALTERED |
68 |
0.0025 |
| 664 |
DIARRHOEA |
1605 |
0.0025 |
| 665 |
HYPOKINESIA |
36 |
0.0025 |
| 666 |
VISION BLURRED |
340 |
0.0025 |
| 667 |
ASTHMA |
279 |
0.0025 |
| 668 |
SINUS TACHYCARDIA |
35 |
0.0025 |
| 669 |
SCRATCH |
26 |
0.0025 |
| 670 |
ARTERIOSCLEROSIS |
23 |
0.0024 |
| 671 |
MANIA |
40 |
0.0024 |
| 672 |
ANKYLOSING SPONDYLITIS |
32 |
0.0024 |
| 673 |
NERVOUSNESS |
126 |
0.0024 |
| 674 |
PSYCHOMOTOR HYPERACTIVITY |
40 |
0.0024 |
| 675 |
EAR INFECTION |
64 |
0.0024 |
| 676 |
DRUG PRESCRIBING ERROR |
46 |
0.0024 |
| 677 |
ATRIAL SEPTAL DEFECT |
20 |
0.0024 |
| 678 |
IMMUNOSUPPRESSION |
21 |
0.0024 |
| 679 |
INJECTION SITE SWELLING |
182 |
0.0024 |
| 680 |
POOR QUALITY PRODUCT ADMINISTERED |
25 |
0.0024 |
| 681 |
DRUG EFFECT INCOMPLETE |
86 |
0.0024 |
| 682 |
ATAXIA |
28 |
0.0024 |
| 683 |
LACRIMATION INCREASED |
71 |
0.0023 |
| 684 |
VERTIGO |
143 |
0.0023 |
| 685 |
HEART RATE IRREGULAR |
53 |
0.0023 |
| 686 |
BALANCE DISORDER |
202 |
0.0023 |
| 687 |
HOT FLUSH |
176 |
0.0023 |
| 688 |
HYPOAESTHESIA ORAL |
35 |
0.0023 |
| 689 |
SKIN INFECTION |
26 |
0.0023 |
| 690 |
SKIN LACERATION |
25 |
0.0023 |
| 691 |
DYSSTASIA |
67 |
0.0023 |
| 692 |
BLOOD PRESSURE FLUCTUATION |
55 |
0.0023 |
| 693 |
TRANSFUSION |
24 |
0.0023 |
| 694 |
NERVOUS SYSTEM DISORDER |
71 |
0.0023 |
| 695 |
EMOTIONAL DISORDER |
69 |
0.0022 |
| 696 |
TEMPERATURE INTOLERANCE |
23 |
0.0022 |
| 697 |
ABORTION SPONTANEOUS |
89 |
0.0022 |
| 698 |
GAIT DISTURBANCE |
425 |
0.0022 |
| 699 |
BACK PAIN |
511 |
0.0022 |
| 700 |
ACUTE KIDNEY INJURY |
335 |
0.0022 |
| 701 |
MICTURITION URGENCY |
25 |
0.0022 |
| 702 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
63 |
0.0022 |
| 703 |
SURGERY |
128 |
0.0022 |
| 704 |
INFECTION |
316 |
0.0022 |
| 705 |
FULL BLOOD COUNT ABNORMAL |
23 |
0.0022 |
| 706 |
CIRCULATORY COLLAPSE |
37 |
0.0022 |
| 707 |
HYPOKALAEMIA |
100 |
0.0022 |
| 708 |
CELLULITIS |
109 |
0.0022 |
| 709 |
SWELLING FACE |
140 |
0.0021 |
| 710 |
NEPHROPATHY |
20 |
0.0021 |
| 711 |
DYSKINESIA |
87 |
0.0021 |
| 712 |
LIMB INJURY |
58 |
0.0021 |
| 713 |
HEAD INJURY |
67 |
0.0021 |
| 714 |
HYPOTENSION |
424 |
0.0021 |
| 715 |
ECONOMIC PROBLEM |
32 |
0.0021 |
| 716 |
OSTEOPENIA |
32 |
0.0021 |
| 717 |
PRODUCT AVAILABILITY ISSUE |
48 |
0.0021 |
| 718 |
JOINT INJURY |
45 |
0.0021 |
| 719 |
OSTEOMYELITIS |
38 |
0.0021 |
| 720 |
SNEEZING |
47 |
0.0021 |
| 721 |
BRADYCARDIA |
111 |
0.0021 |
| 722 |
HYPOGLYCAEMIA |
101 |
0.0021 |
| 723 |
FEAR |
56 |
0.0021 |
| 724 |
SKIN LESION |
57 |
0.0021 |
| 725 |
WEIGHT DECREASED |
577 |
0.0021 |
| 726 |
METABOLIC ACIDOSIS |
66 |
0.0021 |
| 727 |
DYSTONIA |
40 |
0.0021 |
| 728 |
GOUT |
37 |
0.0021 |
| 729 |
ADRENAL INSUFFICIENCY |
25 |
0.0021 |
| 730 |
INTERVERTEBRAL DISC PROTRUSION |
45 |
0.0021 |
| 731 |
INITIAL INSOMNIA |
21 |
0.0020 |
| 732 |
SPINAL FRACTURE |
41 |
0.0020 |
| 733 |
INFLUENZA LIKE ILLNESS |
168 |
0.0020 |
| 734 |
MOUTH ULCERATION |
43 |
0.0020 |
| 735 |
PERIPHERAL COLDNESS |
28 |
0.0020 |
| 736 |
HEART RATE INCREASED |
202 |
0.0020 |
| 737 |
DYSPHAGIA |
193 |
0.0020 |
| 738 |
CARDIOMYOPATHY |
30 |
0.0020 |
| 739 |
TREATMENT NONCOMPLIANCE |
111 |
0.0020 |
| 740 |
INJECTION SITE RASH |
62 |
0.0020 |
| 741 |
PARAESTHESIA ORAL |
29 |
0.0020 |
| 742 |
WRIST FRACTURE |
24 |
0.0020 |
| 743 |
SINUS CONGESTION |
27 |
0.0020 |
| 744 |
FEEDING DISORDER |
40 |
0.0020 |
| 745 |
SLUGGISHNESS |
20 |
0.0020 |
| 746 |
RESPIRATORY TRACT INFECTION |
51 |
0.0020 |
| 747 |
DECREASED ACTIVITY |
21 |
0.0019 |
| 748 |
LOCALISED INFECTION |
47 |
0.0019 |
| 749 |
ANKLE FRACTURE |
30 |
0.0019 |
| 750 |
RECTAL HAEMORRHAGE |
83 |
0.0019 |
| 751 |
MOVEMENT DISORDER |
62 |
0.0019 |
| 752 |
STAPHYLOCOCCAL INFECTION |
63 |
0.0019 |
| 753 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
54 |
0.0019 |
| 754 |
BLOOD PRESSURE SYSTOLIC INCREASED |
37 |
0.0019 |
| 755 |
PYREXIA |
653 |
0.0019 |
| 756 |
PARALYSIS |
27 |
0.0019 |
| 757 |
EATING DISORDER |
40 |
0.0019 |
| 758 |
EYE HAEMORRHAGE |
25 |
0.0019 |
| 759 |
PELVIC PAIN |
34 |
0.0019 |
| 760 |
ACUTE RESPIRATORY FAILURE |
36 |
0.0019 |
| 761 |
HYPONATRAEMIA |
105 |
0.0019 |
| 762 |
INTENTIONAL DOSE OMISSION |
53 |
0.0019 |
| 763 |
LIVER FUNCTION TEST ABNORMAL |
54 |
0.0019 |
| 764 |
APHASIA |
56 |
0.0019 |
| 765 |
ABNORMAL DREAMS |
51 |
0.0018 |
| 766 |
UPPER RESPIRATORY TRACT INFECTION |
85 |
0.0018 |
| 767 |
METASTASES TO BONE |
30 |
0.0018 |
| 768 |
RHINORRHOEA |
118 |
0.0018 |
| 769 |
SINUSITIS |
187 |
0.0018 |
| 770 |
PHARYNGEAL OEDEMA |
28 |
0.0018 |
| 771 |
METASTASES TO LUNG |
21 |
0.0018 |
| 772 |
ABSCESS |
29 |
0.0018 |
| 773 |
ELECTROLYTE IMBALANCE |
21 |
0.0018 |
| 774 |
ARTHRITIS |
142 |
0.0018 |
| 775 |
PALLOR |
49 |
0.0018 |
| 776 |
SKIN DISORDER |
60 |
0.0018 |
| 777 |
NEUROPATHY PERIPHERAL |
171 |
0.0018 |
| 778 |
HYPOCALCAEMIA |
34 |
0.0018 |
| 779 |
ARRHYTHMIA |
85 |
0.0018 |
| 780 |
HUNGER |
25 |
0.0018 |
| 781 |
SKIN ULCER |
46 |
0.0018 |
| 782 |
WHITE BLOOD CELL COUNT INCREASED |
68 |
0.0018 |
| 783 |
TOOTH INFECTION |
23 |
0.0017 |
| 784 |
INJECTION SITE BRUISING |
139 |
0.0017 |
| 785 |
THROAT TIGHTNESS |
47 |
0.0017 |
| 786 |
PROCEDURAL PAIN |
48 |
0.0017 |
| 787 |
HEPATIC CYTOLYSIS |
22 |
0.0017 |
| 788 |
PANCREATITIS |
91 |
0.0017 |
| 789 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
34 |
0.0017 |
| 790 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
94 |
0.0017 |
| 791 |
INTESTINAL OBSTRUCTION |
64 |
0.0017 |
| 792 |
THERAPEUTIC RESPONSE UNEXPECTED |
76 |
0.0017 |
| 793 |
CHOKING |
33 |
0.0017 |
| 794 |
RETCHING |
36 |
0.0017 |
| 795 |
KIDNEY INFECTION |
33 |
0.0017 |
| 796 |
HEART RATE DECREASED |
59 |
0.0017 |
| 797 |
IMMUNODEFICIENCY |
25 |
0.0017 |
| 798 |
ORAL CANDIDIASIS |
22 |
0.0017 |
| 799 |
ULCER |
26 |
0.0016 |
| 800 |
FLUID RETENTION |
83 |
0.0016 |
| 801 |
HYPOTHYROIDISM |
52 |
0.0016 |
| 802 |
GLOMERULAR FILTRATION RATE DECREASED |
20 |
0.0016 |
| 803 |
CHEST DISCOMFORT |
166 |
0.0016 |
| 804 |
EXTRAPYRAMIDAL DISORDER |
40 |
0.0016 |
| 805 |
ACUTE HEPATIC FAILURE |
22 |
0.0016 |
| 806 |
RASH PRURITIC |
87 |
0.0016 |
| 807 |
LABORATORY TEST ABNORMAL |
47 |
0.0016 |
| 808 |
LIMB DISCOMFORT |
49 |
0.0016 |
| 809 |
PNEUMOTHORAX |
25 |
0.0016 |
| 810 |
DERMATITIS |
33 |
0.0016 |
| 811 |
BODY TEMPERATURE INCREASED |
32 |
0.0016 |
| 812 |
SPEECH DISORDER |
82 |
0.0016 |
| 813 |
RESPIRATORY FAILURE |
114 |
0.0016 |
| 814 |
POLLAKIURIA |
65 |
0.0016 |
| 815 |
NEUROTOXICITY |
27 |
0.0015 |
| 816 |
BONE PAIN |
89 |
0.0015 |
| 817 |
ORAL PAIN |
34 |
0.0015 |
| 818 |
INSURANCE ISSUE |
23 |
0.0015 |
| 819 |
COUGH |
421 |
0.0015 |
| 820 |
SKIN BURNING SENSATION |
106 |
0.0015 |
| 821 |
FAECES DISCOLOURED |
32 |
0.0015 |
| 822 |
ERYTHEMA |
302 |
0.0015 |
| 823 |
VISUAL IMPAIRMENT |
182 |
0.0015 |
| 824 |
MELAENA |
32 |
0.0015 |
| 825 |
DYSPHONIA |
85 |
0.0015 |
| 826 |
LEUKOCYTOSIS |
26 |
0.0014 |
| 827 |
ANGINA PECTORIS |
41 |
0.0014 |
| 828 |
URINARY TRACT INFECTION |
244 |
0.0014 |
| 829 |
LEUKOPENIA |
71 |
0.0014 |
| 830 |
PRODUCT DOSE OMISSION IN ERROR |
40 |
0.0014 |
| 831 |
THERAPY CESSATION |
72 |
0.0014 |
| 832 |
PNEUMONITIS |
38 |
0.0014 |
| 833 |
MUSCULOSKELETAL DISCOMFORT |
24 |
0.0014 |
| 834 |
CARDIOGENIC SHOCK |
20 |
0.0014 |
| 835 |
RENAL IMPAIRMENT |
117 |
0.0014 |
| 836 |
HAEMORRHOIDS |
27 |
0.0014 |
| 837 |
FRACTURE |
26 |
0.0014 |
| 838 |
BRONCHITIS |
101 |
0.0014 |
| 839 |
DEHYDRATION |
182 |
0.0014 |
| 840 |
APHONIA |
19 |
0.0014 |
| 841 |
MUSCLE TIGHTNESS |
22 |
0.0014 |
| 842 |
SEPTIC SHOCK |
59 |
0.0014 |
| 843 |
ISCHAEMIC STROKE |
24 |
0.0013 |
| 844 |
HYPOPHAGIA |
34 |
0.0013 |
| 845 |
CARDIAC FAILURE |
106 |
0.0013 |
| 846 |
RENAL DISORDER |
61 |
0.0013 |
| 847 |
NEPHROLITHIASIS |
60 |
0.0013 |
| 848 |
CHRONIC KIDNEY DISEASE |
99 |
0.0013 |
| 849 |
PRODUCT COMPLAINT |
33 |
0.0013 |
| 850 |
ANHEDONIA |
34 |
0.0013 |
| 851 |
HEPATIC FAILURE |
39 |
0.0013 |
| 852 |
BLOOD POTASSIUM INCREASED |
21 |
0.0013 |
| 853 |
MUSCULOSKELETAL CHEST PAIN |
20 |
0.0013 |
| 854 |
BLOOD PRESSURE DECREASED |
85 |
0.0013 |
| 855 |
MULTIPLE FRACTURES |
21 |
0.0013 |
| 856 |
JAUNDICE |
34 |
0.0013 |
| 857 |
ATRIAL FIBRILLATION |
123 |
0.0013 |
| 858 |
SINUS DISORDER |
25 |
0.0013 |
| 859 |
TRANSAMINASES INCREASED |
28 |
0.0013 |
| 860 |
INCREASED APPETITE |
24 |
0.0013 |
| 861 |
PULMONARY EMBOLISM |
119 |
0.0013 |
| 862 |
OROPHARYNGEAL PAIN |
115 |
0.0012 |
| 863 |
DYSGEUSIA |
91 |
0.0012 |
| 864 |
VENTRICULAR TACHYCARDIA |
20 |
0.0012 |
| 865 |
PHOTOSENSITIVITY REACTION |
20 |
0.0012 |
| 866 |
DRUG ADMINISTRATION ERROR |
37 |
0.0012 |
| 867 |
COAGULOPATHY |
20 |
0.0012 |
| 868 |
PULMONARY HYPERTENSION |
25 |
0.0012 |
| 869 |
HAEMATOMA |
31 |
0.0012 |
| 870 |
ACUTE MYOCARDIAL INFARCTION |
35 |
0.0012 |
| 871 |
COLITIS ULCERATIVE |
53 |
0.0012 |
| 872 |
HIP FRACTURE |
38 |
0.0012 |
| 873 |
GASTRITIS |
31 |
0.0012 |
| 874 |
GALLBLADDER DISORDER |
21 |
0.0012 |
| 875 |
PAIN IN JAW |
33 |
0.0012 |
| 876 |
FEMUR FRACTURE |
36 |
0.0012 |
| 877 |
DRY EYE |
58 |
0.0012 |
| 878 |
CHOLELITHIASIS |
38 |
0.0012 |
| 879 |
RENAL FAILURE |
153 |
0.0012 |
| 880 |
END STAGE RENAL DISEASE |
21 |
0.0012 |
| 881 |
PAIN OF SKIN |
31 |
0.0012 |
| 882 |
CHOLESTASIS |
22 |
0.0011 |
| 883 |
INJECTION SITE URTICARIA |
28 |
0.0011 |
| 884 |
TARDIVE DYSKINESIA |
32 |
0.0011 |
| 885 |
RASH ERYTHEMATOUS |
54 |
0.0011 |
| 886 |
DEEP VEIN THROMBOSIS |
73 |
0.0011 |
| 887 |
TUBULOINTERSTITIAL NEPHRITIS |
21 |
0.0011 |
| 888 |
PRODUCT PREPARATION ERROR |
23 |
0.0011 |
| 889 |
HYPERKALAEMIA |
39 |
0.0011 |
| 890 |
UPPER LIMB FRACTURE |
22 |
0.0011 |
| 891 |
HEPATIC FUNCTION ABNORMAL |
41 |
0.0011 |
| 892 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
24 |
0.0011 |
| 893 |
GASTRIC DISORDER |
37 |
0.0011 |
| 894 |
OCULAR HYPERAEMIA |
51 |
0.0011 |
| 895 |
CARDIAC FAILURE CONGESTIVE |
86 |
0.0011 |
| 896 |
RENAL FAILURE ACUTE |
45 |
0.0011 |
| 897 |
INTERNATIONAL NORMALISED RATIO INCREASED |
30 |
0.0011 |
| 898 |
MUSCULOSKELETAL DISORDER |
20 |
0.0010 |
| 899 |
ANAPHYLACTIC REACTION |
58 |
0.0010 |
| 900 |
SKIN DISCOLOURATION |
48 |
0.0010 |
| 901 |
CEREBRAL HAEMORRHAGE |
37 |
0.0010 |
| 902 |
GASTROINTESTINAL HAEMORRHAGE |
85 |
0.0010 |
| 903 |
CONVULSION |
58 |
0.0010 |
| 904 |
AGEUSIA |
25 |
0.0010 |
| 905 |
PRODUCT DOSE OMISSION ISSUE |
294 |
0.0010 |
| 906 |
INFLUENZA |
110 |
0.0010 |
| 907 |
PLEURAL EFFUSION |
60 |
0.0010 |
| 908 |
DYSPNOEA EXERTIONAL |
37 |
0.0010 |
| 909 |
DIVERTICULITIS |
27 |
0.0010 |
| 910 |
ANAEMIA |
185 |
0.0010 |
| 911 |
ANAPHYLACTIC SHOCK |
25 |
0.0010 |
| 912 |
HAEMATOCHEZIA |
53 |
0.0010 |
| 913 |
CEREBROVASCULAR ACCIDENT |
162 |
0.0010 |
| 914 |
BLOOD PRESSURE ABNORMAL |
19 |
0.0010 |
| 915 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
34 |
0.0010 |
| 916 |
ANGIOEDEMA |
42 |
0.0009 |
| 917 |
TRANSIENT ISCHAEMIC ATTACK |
32 |
0.0009 |
| 918 |
FUNGAL INFECTION |
31 |
0.0009 |
| 919 |
INCORRECT DRUG ADMINISTRATION DURATION |
26 |
0.0009 |
| 920 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
43 |
0.0009 |
| 921 |
PSORIASIS |
120 |
0.0009 |
| 922 |
RASH MACULAR |
32 |
0.0009 |
| 923 |
EYE SWELLING |
34 |
0.0009 |
| 924 |
EPISTAXIS |
68 |
0.0009 |
| 925 |
HYPERGLYCAEMIA |
33 |
0.0009 |
| 926 |
FLUSHING |
92 |
0.0009 |
| 927 |
FLATULENCE |
50 |
0.0009 |
| 928 |
SKIN EXFOLIATION |
74 |
0.0009 |
| 929 |
INCORRECT DOSE ADMINISTERED |
197 |
0.0009 |
| 930 |
THROMBOCYTOPENIA |
96 |
0.0009 |
| 931 |
CYSTITIS |
27 |
0.0008 |
| 932 |
PRODUCT DOSE OMISSION |
55 |
0.0008 |
| 933 |
NASAL CONGESTION |
49 |
0.0008 |
| 934 |
MYOCARDIAL INFARCTION |
145 |
0.0008 |
| 935 |
ACCIDENTAL EXPOSURE TO PRODUCT |
85 |
0.0008 |
| 936 |
HAEMOPTYSIS |
23 |
0.0008 |
| 937 |
NEEDLE ISSUE |
24 |
0.0008 |
| 938 |
NEOPLASM MALIGNANT |
55 |
0.0008 |
| 939 |
PANCYTOPENIA |
46 |
0.0008 |
| 940 |
ECZEMA |
43 |
0.0008 |
| 941 |
THROMBOSIS |
66 |
0.0008 |
| 942 |
PRODUCTIVE COUGH |
39 |
0.0008 |
| 943 |
ABASIA |
20 |
0.0008 |
| 944 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
20 |
0.0008 |
| 945 |
COLITIS |
30 |
0.0008 |
| 946 |
RENAL INJURY |
23 |
0.0008 |
| 947 |
LYMPHADENOPATHY |
27 |
0.0008 |
| 948 |
OSTEONECROSIS |
25 |
0.0008 |
| 949 |
THERAPY INTERRUPTED |
54 |
0.0008 |
| 950 |
MULTIPLE SCLEROSIS |
36 |
0.0008 |
| 951 |
ABDOMINAL PAIN LOWER |
19 |
0.0008 |
| 952 |
BLOOD CREATININE INCREASED |
47 |
0.0007 |
| 953 |
INJECTION SITE HAEMORRHAGE |
57 |
0.0007 |
| 954 |
DEVICE MALFUNCTION |
50 |
0.0007 |
| 955 |
PRODUCT STORAGE ERROR |
61 |
0.0007 |
| 956 |
CORONARY ARTERY DISEASE |
21 |
0.0007 |
| 957 |
EXPIRED PRODUCT ADMINISTERED |
23 |
0.0007 |
| 958 |
THROAT IRRITATION |
31 |
0.0007 |
| 959 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
20 |
0.0007 |
| 960 |
DIABETES MELLITUS |
52 |
0.0007 |
| 961 |
HAEMORRHAGE |
70 |
0.0007 |
| 962 |
EYE DISORDER |
22 |
0.0007 |
| 963 |
COVID-19 |
117 |
0.0007 |
| 964 |
BLOOD POTASSIUM DECREASED |
20 |
0.0007 |
| 965 |
NEOPLASM PROGRESSION |
23 |
0.0007 |
| 966 |
VIRAL INFECTION |
22 |
0.0007 |
| 967 |
ALANINE AMINOTRANSFERASE INCREASED |
40 |
0.0007 |
| 968 |
HYPOACUSIS |
28 |
0.0006 |
| 969 |
HERPES ZOSTER |
37 |
0.0006 |
| 970 |
EYE PRURITUS |
21 |
0.0006 |
| 971 |
MALIGNANT NEOPLASM PROGRESSION |
63 |
0.0006 |
| 972 |
VAGINAL HAEMORRHAGE |
26 |
0.0006 |
| 973 |
HAEMOGLOBIN DECREASED |
59 |
0.0006 |
| 974 |
NEUTROPENIA |
78 |
0.0006 |
| 975 |
CATARACT |
34 |
0.0006 |
| 976 |
NEUTROPHIL COUNT DECREASED |
22 |
0.0005 |
| 977 |
PLASMA CELL MYELOMA |
20 |
0.0005 |
| 978 |
MULTIPLE SCLEROSIS RELAPSE |
34 |
0.0005 |
| 979 |
DRY SKIN |
64 |
0.0005 |
| 980 |
BLOOD GLUCOSE DECREASED |
23 |
0.0005 |
| 981 |
DISEASE PROGRESSION |
54 |
0.0005 |
| 982 |
FEBRILE NEUTROPENIA |
28 |
0.0004 |
| 983 |
DISEASE RECURRENCE |
20 |
0.0004 |
| 984 |
DEVICE ISSUE |
36 |
0.0004 |
| 985 |
ACNE |
30 |
0.0004 |
| 986 |
PLATELET COUNT DECREASED |
41 |
0.0004 |
| 987 |
WHITE BLOOD CELL COUNT DECREASED |
41 |
0.0004 |
| 988 |
ASPARTATE AMINOTRANSFERASE INCREASED |
19 |
0.0004 |
| 989 |
BLOOD GLUCOSE INCREASED |
57 |
0.0003 |
| 990 |
DRUG DOSE OMISSION |
41 |
0.0002 |